0
Signin
countryflagCA

888-969-2592

RY 144.17 0.4529% TD 77.39 0.0517% SHOP 78.87 -1.3878% CNR 171.64 0.5625% ENB 50.09 -0.4769% CP 110.62 0.6277% BMO 128.85 -0.548% TRI 233.58 1.1563% CNQ 103.29 -0.174% BN 60.87 -0.2295% ATD 75.6 -1.447% CSU 3697.0 1.1582% BNS 65.76 -0.3485% CM 66.6 -0.5525% SU 54.21 1.1569% TRP 53.15 0.3398% NGT 58.54 -0.3405% WCN 226.5 0.4123% MFC 35.905 0.9986% BCE 46.75 -0.5954%

Devonian Health Group Inc

Healthcare CA GSD

0.2CAD
-(-%)

Last update at 2024-05-15T13:30:00Z

Day Range

0.200.20
LowHigh

52 Week Range

0.110.33
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Type yearly yearly yearly yearly yearly
Date 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Income before tax -4.59961M -3.44830M -3.34638M -4.37478M -3.22258M
Minority interest - - - - -
Net income -4.59961M -3.44830M -3.34638M -4.37478M -2.97942M
Selling general administrative 3.86M 2.70M 1.45M 2.48M 5.42M
Selling and marketing expenses - - - - -
Gross profit 0.89M 0.56M -0.24090M -0.07012M 3.11M
Reconciled depreciation 0.42M 0.86M 1.03M 1.04M 1.02M
Ebit - -2.91257M -2.30596M -4.08513M -3.19047M
Ebitda - -1.64746M -1.52299M -2.57072M -1.64228M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -4.32425M -2.91257M -2.26015M -4.07881M -3.19047M
Other operating expenses - - - - -
Interest expense 0.46M 0.94M 0.79M 0.76M 0.39M
Tax provision - - - 0.00000M -0.24316M
Interest income 0.18M 0.04M - - -
Net interest income -0.27536M -0.89732M -0.79306M -0.51762M -0.55664M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -0.04999M
Total revenue 2.35M 2.31M 1.47M 2.14M 5.94M
Total operating expenses 6.67M 5.22M 3.73M 6.22M 9.13M
Cost of revenue 1.45M 1.74M 1.72M 2.21M 2.82M
Total other income expense net - 0.36M -0.29318M 0.22M 0.52M
Discontinued operations - - - - -
Net income from continuing ops -4.59961M -3.44830M -3.34638M -4.37478M -2.97942M
Net income applicable to common shares - -3.44830M -3.34638M -4.37478M -2.68970M
Preferred stock and other adjustments - - - - -
Breakdown 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Type yearly yearly yearly yearly yearly
Date 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Total assets 19.18M 21.59M 14.61M 16.70M 17.15M
Intangible assets 5.51M 5.64M 6.23M 7.00M 7.77M
Earning assets - - - - -
Other current assets - - - - 0.00553M
Total liab 4.93M 5.31M 7.08M 7.31M 7.07M
Total stockholder equity 14.25M 16.27M 7.52M 9.38M 10.08M
Deferred long term liab - - - - -
Other current liab - - - - -
Common stock - 27.57M 20.21M 19.02M 16.77M
Capital stock 29.35M 27.57M 20.21M 19.02M 16.75M
Retained earnings -25.42635M -20.82675M -17.37844M -14.03206M -9.65729M
Other liab - - - - 0.76M
Good will 4.64M 4.64M 4.64M 4.64M 4.67M
Other assets - - - - -
Cash 5.06M 2.81M 0.34M 0.91M 0.24M
Cash and equivalents - - - - -
Total current liabilities 4.86M 1.04M 1.81M 2.63M 2.01M
Current deferred revenue - - - - -
Net debt - 1.45M 4.91M 3.75M 4.19M
Short term debt - - - - -
Short long term debt 3.58M - - - -
Short long term debt total - - - - -
Other stockholder equity - 5.85M 1.31M 2.84M 2.29M
Property plant equipment - 2.88M 3.07M 3.32M 3.56M
Total current assets 6.34M 8.42M 0.66M 1.74M 1.15M
Long term investments - - - - -
Net tangible assets - 5.99M -3.35349M -2.25848M -1.52723M
Short term investments 0.00000M 5.00M - - -
Net receivables 0.66M 0.34M 0.24M 0.68M 0.60M
Long term debt - 4.26M 5.26M 4.66M 4.44M
Inventory 0.16M 0.15M 0.03M 0.09M 0.19M
Accounts payable 0.75M 0.41M 0.56M 1.54M 0.96M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - 16.00M
Deferred long term asset charges - - - - -
Non current assets total 12.83M 13.17M 13.94M 14.96M 16.00M
Capital lease obligations 0.09M 0.02M 0.02M 0.02M -
Long term debt total - - - - -
Breakdown 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Type yearly yearly yearly yearly yearly
Date 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Investments 5.00M -5.00000M -5.00000M -5.00000M -5.00000M
Change to liabilities - -0.30977M -0.88974M 0.69M 0.00000M
Total cashflows from investing activities - -5.07944M -0.01410M -0.02947M -0.11490M
Net borrowings - -0.52676M 0.05M 0.53M 0.54M
Total cash from financing activities 1.61M 10.41M 1.28M 2.73M 0.54M
Change to operating activities - -0.07027M 0.15M 0.06M 1.02M
Net income -4.59961M -3.44830M -3.34638M -4.37478M -2.68970M
Change in cash 2.26M 2.46M -0.56822M 0.67M -0.73739M
Begin period cash flow 2.81M 0.34M 0.91M 0.24M 0.98M
End period cash flow 5.06M 2.81M 0.34M 0.91M 0.24M
Total cash from operating activities -4.35625M -2.87158M -1.83327M -2.02763M -1.15792M
Issuance of capital stock 1.16M 10.76M 1.18M 2.20M 0.00000M
Depreciation 0.42M 0.85M 1.02M 1.03M 1.01M
Other cashflows from investing activities - -0.00577M -0.01410M -0.02947M -0.02947M
Dividends paid - - - - -
Change to inventory -0.00516M -0.12640M 0.06M 0.10M 0.10M
Change to account receivables -0.55098M -0.09594M 0.29M -0.07676M -0.07676M
Sale purchase of stock - - - - -
Other cashflows from financing activities - - - - -
Change to netincome - 0.31M 0.87M 0.37M -0.61323M
Capital expenditures 0.00000M 0.07M 0.07M 0.07M 0.07M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.31626M -0.60237M -0.38569M 0.77M 0.99M
Stock based compensation 0.48M 0.53M 0.08M 0.34M 0.11M
Other non cash items -0.34871M 0.14M 0.49M 0.43M -0.11202M
Free cash flow -4.35625M -2.95103M -1.84737M -2.05710M -1.27282M

Fundamentals

  • Previous Close 0.20
  • Market Cap27.15M
  • Volume100
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-3.46630M
  • Revenue TTM3.21M
  • Revenue Per Share TTM0.02
  • Gross Profit TTM 0.56M
  • Diluted EPS TTM-0.03

Peer Comparison

Sector: Healthcare Industry: Biotechnology

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
GSD
Devonian Health Group Inc		 - -% 0.20 - - 8.46 1.94 9.22 -9.1214
NGEN
NervGen Pharma Corp		 -0.14 6.67% 1.96 - - - 29.48 -6.9477
ARCH
Arch Biopartners Inc		 -0.04 2.31% 1.69 - - 37.82 - 53.05 -28.1027
MIR
MedMira Inc		 -0.005 5.26% 0.09 - - 170.46 - 189.94 -48.7372
TTI
Thiogenesis Therapeutics Corp.		 0.01 1.47% 0.69 - - - 11.86 -163.0787

Reports Covered

Stock Research & News

View All

Profile

Devonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine, completed Phase IIa clinical trial product for the treatment of ulcerative colitis and atopic dermatitis. The company also develops Pantoprazole Magnesium for the treatment of gastric; Cleo-35 for the treatment of hormonal acne in women; and value-added products for dermo-cosmetics. In addition, the company acquires drug and health product licenses; and distributes pharmaceutical products. Devonian Health Group Inc. was incorporated in 2015 and is headquartered in Québec, Canada.

Devonian Health Group Inc

360, rue des Entrepreneurs, Québec, QC, Canada, G5V 4T1

Key Executives

Name Title Year Born
Ms. Colette Laurin C.A., CPA Interim CFO, Corp. Sec. & Corp. Controller NA
Dr. Andre P. Boulet Ph.D. Chief Scientific Officer 1959
Mr. Pierre J. Montanaro Pres, CEO & Director NA
Mr. Martin Moreau C.F.A., M.Sc. VP of Fin. & Director NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).